v3.26.1
Net Loss Per Share
6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Net Loss Per Share

13. Net Loss Per Share

Basic and diluted net loss per share of common stock were calculated as follows:

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(50,215

)

 

$

(31,629

)

 

$

(91,049

)

 

$

(61,140

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares of common stock outstanding including shares issuable under equity-classified pre-funded warrants, used in computing net loss per share of common stock, basic and diluted

 

 

56,029,124

 

 

 

35,822,308

 

 

 

52,053,022

 

 

 

35,806,591

 

Net loss per share attributable to common stockholders,
     basic and diluted

 

$

(0.90

)

 

$

(0.88

)

 

$

(1.75

)

 

$

(1.71

)

 

Pre-funded warrants have been included in the computation of basic and diluted net loss per share of common stock as the pre-funded warrants are issuable for nominal consideration pursuant to their terms. There were outstanding pre-funded warrants of 1,346,922 and 3,665,999 as of June 30, 2026 and 2025, respectively. The outstanding pre-funded warrants increased the weighted-average number of shares of common stock outstanding by 1,346,922 shares and 1,583,537 shares for the three and six months ended June 30, 2026, respectively, and 3,665,999 shares and 3,793,113 shares for the three and six months ended June 30, 2025, respectively.

The Company’s potential dilutive securities, which include stock options and warrants for the purchase of common stock, have been excluded from the computation of diluted net loss per share as the effect would be antidilutive. Therefore, the weighted-average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share is the same. The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share due to their anti-dilutive effect:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Stock options outstanding

 

 

7,177,580

 

 

 

6,233,517

 

 

 

7,177,580

 

 

 

6,233,517

 

Warrants for the purchase of common stock

 

 

 

 

 

4,677

 

 

 

 

 

 

4,677

 

Total

 

 

7,177,580

 

 

 

6,238,194

 

 

 

7,177,580

 

 

 

6,238,194